Put Options

8 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2022

May 17, 2022

SELL
$86.42 - $109.81 $1.5 Million - $1.91 Million
-17,400 Reduced 18.16%
78,400 $8.25 Million
Q4 2021

Feb 15, 2022

BUY
$98.56 - $119.91 $3.33 Million - $4.05 Million
33,800 Added 54.52%
95,800 $10.3 Million
Q3 2021

Nov 16, 2021

SELL
$91.91 - $110.37 $836,381 - $1 Million
-9,100 Reduced 12.8%
62,000 $6.79 Million
Q2 2021

Aug 16, 2021

SELL
$86.24 - $95.92 $24.2 Million - $26.9 Million
-280,500 Reduced 79.78%
71,100 $6.66 Million
Q1 2021

May 18, 2021

BUY
$71.83 - $95.48 $8.31 Million - $11 Million
115,700 Added 49.05%
351,600 $32.4 Million
Q4 2020

Feb 17, 2021

BUY
$67.0 - $84.39 $1.33 Million - $1.68 Million
19,900 Added 9.21%
235,900 $17.3 Million
Q3 2020

Nov 17, 2020

BUY
$55.23 - $79.93 $9.31 Million - $13.5 Million
168,500 Added 354.74%
216,000 $16.8 Million
Q2 2020

Aug 17, 2020

BUY
$30.2 - $56.98 $1.43 Million - $2.71 Million
47,500 New
47,500 $2.64 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.